Evidence map›Paper›PMID 34343272›Full record

ReviewCardiovascular research2021

Heterogeneity of immune cells in human atherosclerosis revealed by scRNA-Seq.

Jenifer Vallejo, Clément Cochain, Alma Zernecke, Klaus Ley

Open access · bronzeAbstract readReview
In one paragraph

Review in Cardiovascular research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Decoding Immune Cell Doublets in Humans: From Artifacts to Insights.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2026
    Review
  6. Review
  7. Article
  8. Article
  9. Cytotoxic CD4Signal transduction and targeted therapy · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jenifer VallejoDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0002-4836-8854
Clément CochainInstitute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.ORCID 0000-0002-0340-1745
Alma ZerneckeInstitute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.ORCID 0000-0001-8551-4729
Klaus LeyDivision of Inflammation Biology, La Jolla Institute for Immunology, La Jolla, CA, USA.ORCID 0000-0001-9339-3672
La Jolla Institute for Immunology · USUniversitätsklinikum Würzburg · DE

Funding

Project 4: APOB-specific CD4 and CD8 T cells exacerbate atherosclerosisP01HL136275 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI Catherine C Hedrick · 2017 to 2026
$25.5M
Vascular macrophages and T cells in atherosclerosisR35HL145241 · NHLBI · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI LEY, KLAUS F. · 2019 to 2025
$5.9M
Immunophenotyping for precision medicine for cardiovascular disease in people living with HIVR01HL148094 · NHLBI · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI KAPLAN, ROBERT C, LEY, KLAUS F. · 2019 to 2022
$3.3M
Immunologic, Inflammatory, and Clinical contributors to HIV-Related Heart Failure with Preserved Ejection Fraction (HFpEF)R01HL156792 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FEINSTEIN, MATTHEW JOEL · 2021 to 2024
$2.9M
NHLBI NIH HHS P01 HL136275NHLBI NIH HHS R01 HL148094NHLBI NIH HHS R01 HL156792NHLBI NIH HHS R35 HL145241
6 · The paper itself

Abstract

Immune cells in atherosclerosis include T, B, natural killer (NK) and NKT cells, macrophages, monocytes, dendritic cells (DCs), neutrophils, and mast cells. Advances in single-cell RNA sequencing (sRNA-Seq) have refined our understanding of immune cell subsets. Four recent studies have used scRNA-Seq of immune cells in human atherosclerotic lesions and peripheral blood mononuclear cells (PBMCs), some including cell surface phenotypes revealed by oligonucleotide-tagged antibodies, which confirmed known and identified new immune cell subsets and identified genes significantly up-regulated in PBMCs from HIV+ subjects with atherosclerosis compared to PBMCs from matched HIV+ subjects without atherosclerosis. The ability of scRNA-Seq to identify cell types is greatly augmented by adding cell surface phenotype using antibody sequencing. In this review, we summarize the latest data obtained by scRNA-Seq on plaques and human PBMCs in human subjects with atherosclerosis.

Indexed as

Gene Expression ProfilingGenetic HeterogeneityPlaque, AtheroscleroticRNA-SeqSingle-Cell AnalysisTranscriptomeAnimalsAtherosclerosisHumansImmune SystemImmunophenotypingLeukocytesMiceMyeloid CellsPhenotypeAntibodiesAtherosclerosisHumanscRNA-SeqTranscriptomes

Identifiers

PMID34343272
PMCPMC8921647
OpenAlexW3189198670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.